Xianglin Zuo
Nanjing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Integrating Plasma Proteomics and Polygenic Risk Scores for the Prediction of Lung Cancer Risk.
Journal: International journal of cancer
Published: September 12, 2025
TNFRSF19 within the 13q12.12 Risk Locus Functions as a Lung Cancer Suppressor by Binding Wnt3a to Inhibit Wnt/β-Catenin Signaling.
Journal: Molecular cancer research : MCR
Published: February 26, 2023
Enhanced Detection of Landmark Minimal Residual Disease in Lung Cancer Using Cell-free DNA Fragmentomics.
Journal: Cancer research communications
Published: September 11, 2022
Cancer-associated fibroblast-specific lncRNA LINC01614 enhances glutamine uptake in lung adenocarcinoma.
Journal: Journal of hematology & oncology
Published: June 28, 2022
Intratumor microbiome-derived butyrate promotes lung cancer metastasis.
Journal: Cell reports. Medicine
Published: May 18, 2022
Knockdown CYP2S1 inhibits lung cancer cells proliferation and migration.
Journal: Cancer biomarkers : section A of Disease markers
Published: July 19, 2021
The enhancer rare germline variation rs548071605 contributes to lung cancer development.
Journal: Human mutation
Published: March 25, 2021
Heritable Variants in the Chromosome 1q22 Locus Increase Gastric Cancer Risk via Altered Chromatin Looping and Increased UBAP2L Expression.
Journal: Molecular cancer research : MCR
Published: January 11, 2021
The inherited variations of a p53-responsive enhancer in 13q12.12 confer lung cancer risk by attenuating TNFRSF19 expression.
Journal: Genome biology
Published: October 27, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026